Señales en vivo de MIRO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (12 dic 2023 @ 16:00):

Stats
Volumen de hoy	631 561
Volumen promedio	163 022
Capitalización de mercado	92.95M
EPS	$0 ( 2024-03-29 )
Próxima fecha de ganancias	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.97
ATR14	$0.0740 (2.18%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-12	United Therapeutics Corp	Sell	0	Common Stock
2023-12-12	Heine Lisa Wipperman	Sell	66 943	Common Stock
2023-12-13	Heine Lisa Wipperman	Sell	67 413	Common Stock
2023-12-12	Maag Peter	Sell	62 092	Common Stock
2023-12-13	Maag Peter	Sell	58 368	Common Stock

INSIDER POWER
-56.82
Last 96 transactions
Buy: 3 749 163 \| Sell: 3 803 884

Volumen Correlación

Largo: 0.23 (neutral)

Corto: 0.00 (neutral)

Signal:(75.317) Neutral

Miromatrix Medical Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Miromatrix Medical Inc. Correlación - Moneda/Commodity

0.87
( strong )

0.88
( strong )

-0.61
( weak negative )

0.72
( moderate )

0.08
( neutral )

-0.38
( neutral )

Miromatrix Medical Inc. Finanzas

Annual	2022
Ingresos:	$953 470
Beneficio Bruto:	$453 470 (47.56 %)
EPS:	$-1.450

FY	2022
Ingresos:	$953 470
Beneficio Bruto:	$453 470 (47.56 %)
EPS:	$-1.450

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$-500 000 (0.00 %)
EPS:	$-1.400

FY	2020
Ingresos:	$46 530.00
Beneficio Bruto:	$-453 470 (-974.58 %)
EPS:	$-0.980

Financial Reports:

No articles found.

Miromatrix Medical Inc.

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.